MART-1(51-61)

MART-1(51-61) is a synthetic peptide fragment derived from the melanoma antigen recognized by T-cells 1 (MART-1), specifically encompassing amino acid residues 51 to 61. As a well-characterized epitope, this peptide plays a significant role in immunological studies focused on melanoma and antigen-specific T-cell responses. Its defined sequence and immunogenic properties make it a valuable molecular tool for dissecting cellular immune mechanisms, facilitating antigen presentation research, and supporting the development of immunological assays. Researchers leverage its specificity to study antigen recognition, T-cell activation, and related signaling pathways in the context of melanoma and tumor immunology.

Immunological assay development: MART-1(51-61) is widely employed as a reference antigen in the development and optimization of immunological assays, such as ELISPOT, intracellular cytokine staining, and tetramer-based flow cytometry. By providing a defined peptide epitope, it enables precise quantification and characterization of MART-1-specific cytotoxic T lymphocyte (CTL) responses. This is particularly valuable in studies aiming to monitor immune reactivity in various experimental systems, including human peripheral blood mononuclear cells or murine models expressing human HLA molecules.

Epitope mapping and T-cell specificity studies: The peptide serves as a critical tool for mapping T-cell epitopes and understanding the specificity of T-cell receptors (TCRs) for melanoma-associated antigens. By presenting MART-1(51-61) in the context of major histocompatibility complex (MHC) molecules, researchers can delineate the fine specificity of TCR recognition, analyze cross-reactivity with related peptides, and assess the impact of sequence variations on immune recognition. These studies provide foundational insights into antigen processing and presentation pathways relevant to tumor immunology.

Antigen presentation and MHC binding assays: As a defined MHC class I-restricted epitope, MART-1(51-61) is instrumental in evaluating the efficiency of antigen processing and presentation by professional antigen-presenting cells (APCs). Researchers utilize the peptide to load APCs, including dendritic cells and B cells, to assess their capacity to present antigenic peptides via HLA-A2 and related alleles. This supports detailed investigations into peptide-MHC binding affinity, stability, and the dynamics of peptide exchange, which are essential for understanding immune surveillance and designing antigen-specific immunotherapies.

Peptide-based vaccine research: In the context of preclinical immunotherapy studies, MART-1(51-61) serves as a model antigen for evaluating peptide-based vaccination strategies targeting tumor-associated antigens. Its use enables the assessment of immunogenicity, induction of antigen-specific T-cell responses, and optimization of adjuvant formulations in experimental models. By facilitating the rational design and testing of peptide vaccines, it contributes to the advancement of targeted immunotherapeutic approaches in oncology research.

Quality control and standardization: The synthetic nature and sequence fidelity of MART-1(51-61) make it an ideal standard for quality control in peptide synthesis and assay calibration workflows. Laboratories utilize this peptide to validate analytical methods, confirm batch-to-batch consistency, and ensure reproducibility in experimental protocols. Its inclusion as a control reagent supports robust assay performance and enhances confidence in immunological data generated across diverse research settings.

1. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

2. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

3. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

4. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs

5. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance